福泰制药Vertex Pharmaceuticals Inc. (VRTX) 2011年10-K年度报告「NASDAQ」.pdf

1、VERTEX PHARMACEUTICALS INC/MAFORM 10-K(Annual Report)Filed 02/22/12 for the Period Ending 12/31/11 Address130 WAVERLY STREETCAMBRIDGE,MA 02139-4242Telephone6165776000CIK0000875320SymbolVRTXSIC Code2834-Pharmaceutical PreparationsIndustryBiotechnology&DrugsSectorHealthcareFiscal Year12/31http:/www.ed

2、gar- Copyright 2012,EDGAR Online,Inc.All Rights Reserved.Distribution and use of this document restricted under EDGAR Online,Inc.Terms of Use.Use these links to rapidly review the document TABLE OF CONTENTS PART IV Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON,D.C.205

3、49 FORM 10-K Commission file number 000-19319 Vertex Pharmaceuticals Incorporated (Exact name of registrant as specified in its charter)Registrants telephone number,including area code(617)444-6100 Securities registered pursuant to Section 12(b)of the Exchange Act:Securities registered pursuant to S

4、ection 12(g)of the Exchange Act:None Indicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes?No?ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31,2011 or?TRANSITI

5、ON REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Massachusetts 04-3039129(State or other jurisdiction of incorporation or organization)(I.R.S.Employer Identification No.)130 Waverly Street,Cambridge,Massachusetts 02139-4242(Address of

6、principal executive offices)(Zip Code)Title of Each Class Name of Each Exchange on Which Registered Common Stock,$0.01 Par Value Per Share The NASDAQ Global Select Market Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d)of the Exchange A